Company attributes
Industry
Location
Founder
Pitchbook URL
Legal Name
Immusoft Corporation
Number of Employees (Ranges)
11 – 50
Email Address
info@immusoft.com
Full Address
454 North 34th Street Seattle, WA 98103 United States
CIK Number
Investors
DUNS Number
831407775
Founded Date
2009
0Total Funding Amount (USD)
37,917,000
Latest Funding Round Date
September 2020
Latest Funding Type
Patents Assigned (Count)
3
Country
Other attributes
Company Operating Status
Active
Immusoft is developing an approach to sustained delivery of protein therapeutics using a patient's own cells. The approach is called Immune System Programming (ISPTM). ISP entails collecting a type of the patient's immune cells, called B cells. In response to immune stimulation, B cells can turn into a biofactory state known as a plasma cell. Plasma cells manufacture and secrete thousands of antibodies per second. We harness this biofactory capability of the plasma cell by programming B cells to produce a given protein therapeutics.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
